Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. [electronic resource]
Producer: 20120112Description: E381-9 p. digitalISSN:- 1399-0012
- Anti-Bacterial Agents -- therapeutic use
- Azithromycin -- therapeutic use
- Bronchiolitis Obliterans -- complications
- Chemokine CCL3 -- metabolism
- Chronic Disease
- Female
- Flow Cytometry
- Follow-Up Studies
- Graft Rejection -- drug therapy
- Humans
- Interleukin-8 -- metabolism
- Lung Transplantation -- adverse effects
- Male
- Middle Aged
- Pneumonia -- drug therapy
- Prognosis
- Respiratory Function Tests
- Retrospective Studies
- Survival Rate
- Transplantation, Homologous
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.